$7.91 Billion is the total value of Perceptive Advisors's 139 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 51.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Sell | MIRATI THERAPEUTICS INC | $595,183,000 | -26.6% | 3,474,505 | -5.9% | 7.53% | -13.5% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $477,827,000 | +0.2% | 7,756,928 | +15.7% | 6.04% | +18.1% |
| RETROPHIN INCnote 2.500% 9/1 | $474,750,000 | +7.3% | 45,000,000 | 0.0% | 6.00% | +26.4% | ||
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $356,808,000 | +17.8% | 4,849,912 | +16.1% | 4.51% | +38.8% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $273,915,000 | -35.6% | 8,651,785 | -5.6% | 3.46% | -24.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $225,870,000 | -61.0% | 22,861,329 | -9.0% | 2.86% | -54.1% |
| BIIB | New | BIOGEN INCcall | $209,253,000 | – | 748,000 | +100.0% | 2.65% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $206,139,000 | -16.1% | 5,058,642 | -10.9% | 2.61% | -1.2% |
| NVTA | Sell | INVITAE CORP | $204,831,000 | -32.7% | 5,360,673 | -26.4% | 2.59% | -20.7% |
| COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $189,560,000 | +9.4% | 17,500,000 | 0.0% | 2.40% | +28.9% | ||
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $188,682,000 | -16.4% | 2,050,002 | -33.5% | 2.39% | -1.4% |
| AVIR | ATEA PHARMACEUTICALS INC | $184,693,000 | +42.2% | 3,109,224 | 0.0% | 2.34% | +67.6% | |
| VBIV | VBI VACCINES INC CDA | $171,182,000 | +13.1% | 55,042,465 | 0.0% | 2.16% | +33.3% | |
| BIIB | New | BIOGEN INCput | $167,850,000 | – | 600,000 | +100.0% | 2.12% | – |
| LABP | New | LANDOS BIOPHARMA INC | $140,967,000 | – | 14,869,915 | +100.0% | 1.78% | – |
| ZYME | Buy | ZYMEWORKS INC | $136,769,000 | -32.7% | 4,330,868 | +0.7% | 1.73% | -20.7% |
| NEVRO CORPnote 2.750% 4/0 | $135,324,000 | -18.2% | 9,000,000 | 0.0% | 1.71% | -3.6% | ||
| OM | Sell | OUTSET MED INC | $129,858,000 | -19.8% | 2,387,535 | -16.2% | 1.64% | -5.5% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $127,243,000 | -31.7% | 2,867,771 | -15.6% | 1.61% | -19.5% |
| CCCC | C4 THERAPEUTICS INC | $116,835,000 | +11.7% | 3,158,566 | 0.0% | 1.48% | +31.5% | |
| NVRO | Sell | NEVRO CORP | $113,295,000 | -33.0% | 812,154 | -16.9% | 1.43% | -21.1% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $103,402,000 | +139.8% | 8,703,879 | +38.5% | 1.31% | +182.5% |
| MGTX | MEIRAGTX HLDGS PLC | $93,374,000 | -11.0% | 6,933,277 | 0.0% | 1.18% | +4.9% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $91,593,000 | -49.7% | 941,832 | -50.4% | 1.16% | -40.7% |
| ALBO | ALBIREO PHARMA INC | $83,195,000 | -6.0% | 2,360,139 | 0.0% | 1.05% | +10.7% | |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $82,362,000 | -13.5% | 3,298,419 | -5.6% | 1.04% | +2.0% |
| KRON | KRONOS BIO INC | $79,671,000 | -4.1% | 2,780,097 | 0.0% | 1.01% | +13.1% | |
| SLDB | Buy | SOLID BIOSCIENCES INC | $74,171,000 | -9.4% | 13,412,552 | +24.1% | 0.94% | +6.7% |
| RLAY | Sell | RELAY THERAPEUTICS INC | $69,766,000 | -27.9% | 2,018,097 | -13.4% | 0.88% | -15.1% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $68,632,000 | -15.5% | 4,697,612 | +0.6% | 0.87% | -0.3% |
| MGNX | Buy | MACROGENICS INC | $68,416,000 | +137.3% | 2,148,060 | +70.3% | 0.86% | +179.9% |
| CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $63,749,000 | -15.4% | 4,643,095 | +2.2% | 0.81% | -0.4% |
| ATHA | Buy | ATHIRA PHARMA INC | $63,037,000 | -40.9% | 3,425,916 | +10.0% | 0.80% | -30.4% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $61,735,000 | +135.4% | 987,287 | +41.7% | 0.78% | +177.9% |
| KDMN | KADMON HLDGS INC | $61,117,000 | -6.3% | 15,711,334 | 0.0% | 0.77% | +10.4% | |
| NARI | Sell | INARI MED INC | $60,467,000 | +3.6% | 565,113 | -15.5% | 0.76% | +22.2% |
| QTNT | QUOTIENT LTD | $59,619,000 | -29.4% | 16,200,818 | 0.0% | 0.75% | -16.8% | |
| MORF | Buy | MORPHIC HLDG INC | $59,365,000 | +263.3% | 938,140 | +92.6% | 0.75% | +329.1% |
| ATNX | ATHENEX INC | $57,330,000 | -61.7% | 13,532,467 | 0.0% | 0.72% | -54.9% | |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $55,354,000 | – | 3,314,032 | +100.0% | 0.70% | – |
| RAPT | Buy | RAPT THERAPEUTICS INC | $55,000,000 | +76.5% | 2,477,481 | +57.1% | 0.70% | +108.4% |
| VRCA | Buy | VERRICA PHARMACEUTICALS INC | $54,698,000 | +39.3% | 3,610,412 | +5.9% | 0.69% | +64.4% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $51,606,000 | -0.1% | 3,659,381 | 0.0% | 0.65% | +17.9% | |
| VERU | Buy | VERU INC | $47,963,000 | +70.6% | 4,451,342 | +37.0% | 0.61% | +101.0% |
| EXAS | New | EXACT SCIENCES CORP | $46,587,000 | – | 353,523 | +100.0% | 0.59% | – |
| VYNE | New | VYNE THERAPEUTICS INC | $46,368,000 | – | 6,773,954 | +100.0% | 0.59% | – |
| KOD | Sell | KODIAK SCIENCES INC | $44,110,000 | -60.0% | 389,008 | -48.2% | 0.56% | -52.9% |
| TARS | TARSUS PHARMACEUTICALS INC | $41,127,000 | -23.2% | 1,296,416 | 0.0% | 0.52% | -9.6% | |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $41,017,000 | +137.4% | 7,695,505 | +16.7% | 0.52% | +180.5% |
| ALLO | ALLOGENE THERAPEUTICS INC | $40,376,000 | +39.9% | 1,143,790 | 0.0% | 0.51% | +64.8% | |
| ARNA | ARENA PHARMACEUTICALS INC | $39,900,000 | -9.7% | 575,007 | 0.0% | 0.50% | +6.5% | |
| BEAM | New | BEAM THERAPEUTICS INC | $37,832,000 | – | 537,635 | +100.0% | 0.48% | – |
| LYRA | Sell | LYRA THERAPEUTICS INC | $37,349,000 | +1.7% | 3,222,560 | -0.0% | 0.47% | +19.8% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $36,386,000 | – | 1,410,305 | +100.0% | 0.46% | – |
| FMTX | FORMA THERAPEUTICS HOLDINGS | $35,025,000 | -19.7% | 1,250,000 | 0.0% | 0.44% | -5.3% | |
| AGRX | AGILE THERAPEUTICS INC | $33,113,000 | -27.5% | 15,919,925 | 0.0% | 0.42% | -14.5% | |
| PRVB | Sell | PROVENTION BIO INC | $29,932,000 | -58.2% | 2,852,058 | -32.5% | 0.38% | -50.7% |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $29,360,000 | -41.2% | 797,404 | -23.9% | 0.37% | -30.7% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $29,272,000 | – | 175,000 | +100.0% | 0.37% | – |
| ADMA | ADMA BIOLOGICS INC | $29,189,000 | -9.7% | 16,584,802 | 0.0% | 0.37% | +6.3% | |
| NUVB | New | NUVATION BIO INC | $29,041,000 | – | 3,041,004 | +100.0% | 0.37% | – |
| ISEE | Buy | IVERIC BIO INC | $28,338,000 | -8.5% | 4,585,512 | +2.3% | 0.36% | +7.8% |
| IMTX | IMMATICS N.V | $28,025,000 | +3.9% | 2,500,000 | 0.0% | 0.35% | +22.5% | |
| COGT | COGENT BIOSCIENCES INC | $27,997,000 | -21.8% | 3,188,750 | 0.0% | 0.35% | -7.8% | |
| ONCR | ONCORUS INC | $27,700,000 | -56.9% | 1,989,987 | 0.0% | 0.35% | -49.3% | |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $27,143,000 | -67.0% | 409,341 | -61.8% | 0.34% | -61.1% |
| STOK | STOKE THERAPEUTICS INC | $26,100,000 | -37.3% | 671,978 | 0.0% | 0.33% | -26.2% | |
| ATEC | New | ALPHATEC HOLDINGS INC | $25,490,000 | – | 1,800,180 | +100.0% | 0.32% | – |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $24,554,000 | -54.9% | 746,557 | -15.7% | 0.31% | -46.8% |
| VRNA | VERONA PHARMA PLCsponsored ads | $24,151,000 | +19.4% | 2,888,889 | 0.0% | 0.30% | +40.6% | |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $23,970,000 | -24.0% | 1,099,028 | -11.1% | 0.30% | -10.4% |
| HCAT | Buy | HEALTH CATALYST INC | $23,670,000 | +97.0% | 506,084 | +83.3% | 0.30% | +131.8% |
| FBRX | Buy | FORTE BIOSCIENCES INC | $23,475,000 | +84.2% | 685,000 | +95.7% | 0.30% | +116.8% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $23,185,000 | -43.8% | 978,277 | -52.5% | 0.29% | -33.7% |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $20,905,000 | -20.4% | 1,950,167 | -12.8% | 0.26% | -6.4% |
| DRNA | DICERNA PHARMACEUTICALS INC | $20,456,000 | +16.1% | 800,000 | 0.0% | 0.26% | +37.0% | |
| ONEM | 1LIFE HEALTHCARE INC | $20,315,000 | -10.5% | 519,844 | 0.0% | 0.26% | +5.3% | |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $20,220,000 | – | 6,000,000 | +100.0% | 0.26% | – |
| FREQ | Sell | FREQUENCY THERAPEUTICS INC | $20,080,000 | -82.5% | 2,113,661 | -35.2% | 0.25% | -79.4% |
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $19,298,000 | -22.4% | 444,878 | -25.9% | 0.24% | -8.6% |
| SILK | Sell | SILK RD MED INC | $17,226,000 | -41.2% | 340,100 | -26.9% | 0.22% | -30.6% |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $17,028,000 | – | 400,000 | +100.0% | 0.22% | – |
| PCVX | VAXCYTE INC | $16,787,000 | -25.7% | 850,000 | 0.0% | 0.21% | -12.4% | |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $16,650,000 | -1.4% | 2,153,974 | -16.4% | 0.21% | +16.6% |
| NEPT | Sell | NEPTUNE WELLNESS SOLUTIONS I | $16,555,000 | -52.2% | 12,849,706 | -42.2% | 0.21% | -43.8% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $16,380,000 | – | 650,000 | +100.0% | 0.21% | – |
| LPTX | LEAP THERAPEUTICS INC | $16,105,000 | -15.6% | 8,476,496 | 0.0% | 0.20% | -0.5% | |
| CMIIU | New | CM LIFE SCIENCES II INCunit 02/25/2028 | $16,000,000 | – | 1,250,000 | +100.0% | 0.20% | – |
| NBTX | Sell | NANOBIOTIX SAsponsored ads | $15,939,000 | -12.2% | 1,059,800 | -3.7% | 0.20% | +3.6% |
| RACA | THERAPEUTICS ACQUISITION COR | $15,765,000 | -24.5% | 1,500,000 | 0.0% | 0.20% | -11.2% | |
| ACCD | Sell | ACCOLADE INC | $15,686,000 | -42.4% | 345,741 | -44.8% | 0.20% | -32.4% |
| HCAQ | New | HEALTHCOR CATALIO ACQU CORPcl a shrs | $14,880,000 | – | 1,500,000 | +100.0% | 0.19% | – |
| ADPT | Sell | ADAPTIVE BIOTECHNOLOGIES COR | $14,204,000 | -73.5% | 352,804 | -61.0% | 0.18% | -68.6% |
| VTRS | VIATRIS INC | $14,032,000 | -25.5% | 1,004,419 | 0.0% | 0.18% | -12.4% | |
| ACHL | New | ACHILLES THERAPEUTICS PLCsponsored ads | $12,501,000 | – | 755,375 | +100.0% | 0.16% | – |
| CNCE | CONCERT PHARMACEUTICALS INC | $10,731,000 | -60.5% | 2,150,641 | 0.0% | 0.14% | -53.4% | |
| BLSA | BCLS ACQUISITION CORP | $10,570,000 | -5.1% | 1,000,000 | 0.0% | 0.13% | +11.7% | |
| CLOV | New | CLOVER HEALTH INVESTMENTS CO | $10,322,000 | – | 1,500,000 | +100.0% | 0.13% | – |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $10,298,000 | -43.3% | 311,673 | -38.0% | 0.13% | -33.3% |
| RACB | New | RESEARCH ALLIANCE CORP II | $10,250,000 | – | 1,000,000 | +100.0% | 0.13% | – |
| TSHA | TAYSHA GENE THERAPIES INC | $9,548,000 | -23.5% | 470,440 | 0.0% | 0.12% | -9.7% | |
| XENE | New | XENON PHARMACEUTICALS INC | $9,219,000 | – | 515,042 | +100.0% | 0.12% | – |
| PSTX | POSEIDA THERAPEUTICS INC | $7,523,000 | -12.9% | 787,745 | 0.0% | 0.10% | +2.2% | |
| FGEN | New | FIBROGEN INCput | $6,942,000 | – | 200,000 | +100.0% | 0.09% | – |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $6,918,000 | -44.1% | 313,300 | -21.7% | 0.09% | -34.6% |
| TARA | Sell | PROTARA THERAPEUTICS INC | $6,637,000 | -55.0% | 421,642 | -30.7% | 0.08% | -46.8% |
| New | DARIOHEALTH CORP | $6,314,000 | – | 327,869 | +100.0% | 0.08% | – | |
| AMWL | Sell | AMERICAN WELL CORPcl a | $6,166,000 | -53.6% | 355,000 | -32.4% | 0.08% | -45.5% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $6,037,000 | -9.5% | 270,000 | -10.0% | 0.08% | +5.6% |
| VINC | VINCERX PHARMA INC | $5,790,000 | -7.7% | 300,000 | 0.0% | 0.07% | +9.0% | |
| New | CATABASIS PHARMACEUTICALS IN | $5,588,000 | – | 1,933,551 | +100.0% | 0.07% | – | |
| BCTG | BCTG ACQUISITION CORP | $5,560,000 | -2.8% | 500,000 | 0.0% | 0.07% | +14.8% | |
| PHR | PHREESIA INC | $5,210,000 | -4.0% | 100,000 | 0.0% | 0.07% | +13.8% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $5,036,000 | -12.6% | 450,000 | 0.0% | 0.06% | +3.2% | |
| LGVU | New | LONGVIEW ACQUISITION CORP IIunit 99/99/9999 | $5,020,000 | – | 500,000 | +100.0% | 0.06% | – |
| CHFWU | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $4,880,000 | -6.8% | 500,000 | 0.0% | 0.06% | +10.7% | |
| DFHTU | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $3,930,000 | -12.7% | 300,000 | 0.0% | 0.05% | +4.2% | |
| TXMD | New | THERAPEUTICSMD INC | $3,685,000 | – | 2,750,000 | +100.0% | 0.05% | – |
| MRUS | New | MERUS N V | $3,655,000 | – | 175,000 | +100.0% | 0.05% | – |
| TLIS | New | TALIS BIOMEDICAL CORP | $3,212,000 | – | 250,000 | +100.0% | 0.04% | – |
| VRAY | Sell | VIEWRAY INC | $3,270,000 | -65.1% | 751,748 | -69.3% | 0.04% | -59.4% |
| LSAQ | LIFESCI ACQUISITION II CORP | $3,042,000 | -5.0% | 300,000 | 0.0% | 0.04% | +11.8% | |
| SGTX | SIGILON THERAPEUTICS INC | $2,794,000 | -53.5% | 125,000 | 0.0% | 0.04% | -45.3% | |
| RGNX | New | REGENXBIO INC | $2,363,000 | – | 69,283 | +100.0% | 0.03% | – |
| GRTX | Sell | GALERA THERAPEUTICS INC | $2,246,000 | -32.5% | 254,664 | -21.6% | 0.03% | -22.2% |
| MOTS | Sell | MOTUS GI HLDGS INC | $2,070,000 | -47.0% | 1,800,542 | -57.2% | 0.03% | -38.1% |
| PLXP | New | PLX PHARMA INC | $2,006,000 | – | 222,180 | +100.0% | 0.02% | – |
| CMLF | New | CM LIFE SCIENCES INC | $1,891,000 | – | 127,000 | +100.0% | 0.02% | – |
| BFLYWS | New | BUTTERFLY NETWORK INC*w exp 05/27/202 | $1,505,000 | – | 233,333 | +100.0% | 0.02% | – |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,238,000 | -28.0% | 139,890 | 0.0% | 0.02% | -11.1% | |
| RACE | FERRARI N V | $1,298,000 | -8.8% | 6,200 | 0.0% | 0.02% | +6.7% | |
| SRRA | SIERRA ONCOLOGY INC | $1,148,000 | +7.5% | 66,655 | 0.0% | 0.02% | +36.4% | |
| VINCW | VINCERX PHARMA INC*w exp 12/24/202 | $1,212,000 | +22.4% | 300,000 | 0.0% | 0.02% | +36.4% | |
| SCPEWS | New | SC HEALTH CORP*w exp 99/99/999 | $945,000 | – | 500,000 | +100.0% | 0.01% | – |
| PHVS | New | PHARVARIS N V | $755,000 | – | 27,000 | +100.0% | 0.01% | – |
| CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $573,000 | – | 133,066 | +100.0% | 0.01% | – |
| CVM | New | CEL-SCI CORP | $513,000 | – | 33,700 | +100.0% | 0.01% | – |
| SANA | New | SANA BIOTECHNOLOGY INC | $335,000 | – | 10,000 | +100.0% | 0.00% | – |
| DFHT | DEERFIELD HEALTHCARE TECH AC | $242,000 | -22.4% | 20,000 | 0.0% | 0.00% | 0.0% | |
| OTLKW | Exit | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $0 | – | -420,875 | -100.0% | -0.00% | – |
| IPOF | Exit | SOCIAL CAPITAL HEDOSOPHIA HLD | $0 | – | -40,000 | -100.0% | -0.01% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -25,000 | -100.0% | -0.01% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -20,000 | -100.0% | -0.01% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $0 | – | -400,000 | -100.0% | -0.02% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -150,000 | -100.0% | -0.04% | – |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -411,818 | -100.0% | -0.04% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -203,591 | -100.0% | -0.04% | – |
| AVXL | Exit | ANAVEX LIFE SCIENCES CORP | $0 | – | -780,007 | -100.0% | -0.04% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -77,500 | -100.0% | -0.05% | – |
| AQST | Exit | AQUESTIVE THERAPEUTICS INC | $0 | – | -1,385,720 | -100.0% | -0.08% | – |
| SHC | Exit | SOTERA HEALTH CO | $0 | – | -300,000 | -100.0% | -0.09% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.09% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -224,224 | -100.0% | -0.10% | – |
| MRVI | Exit | MARAVAI LIFESCIENCES HLDGS I | $0 | – | -350,000 | -100.0% | -0.10% | – |
| CRIS | Exit | CURIS INC | $0 | – | -1,250,000 | -100.0% | -0.11% | – |
| SCPEU | Exit | SC HEALTH CORPunit 99/99/9999 | $0 | – | -1,000,000 | -100.0% | -0.12% | – |
| PPH | Exit | VANECK VECTORS ETF TRput | $0 | – | -200,000 | -100.0% | -0.14% | – |
| LGVWU | Exit | LONGVIEW ACQUISITION CORPunit 99/99/9999 | $0 | – | -700,000 | -100.0% | -0.16% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -2,400,000 | -100.0% | -0.20% | – |
| RGEN | Exit | REPLIGEN CORP | $0 | – | -97,500 | -100.0% | -0.20% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -2,500,000 | -100.0% | -0.21% | – |
| AMRS | Exit | AMYRIS INC | $0 | – | -3,333,332 | -100.0% | -0.22% | – |
| GERN | Exit | GERON CORP | $0 | – | -13,461,538 | -100.0% | -0.23% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -337,800 | -100.0% | -0.24% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -1,195,336 | -100.0% | -0.28% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -385,000 | -100.0% | -0.28% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -55,175 | -100.0% | -0.29% | – |
| XBI | Exit | SPDR SER TRput | $0 | – | -200,000 | -100.0% | -0.30% | – |
| VYNE | Exit | VYNE THERAPEUTICS INC | $0 | – | -22,876,410 | -100.0% | -0.39% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -440,000 | -100.0% | -0.41% | – |
| UROV | Exit | UROVANT SCIENCES LTD | $0 | – | -3,116,831 | -100.0% | -0.54% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -1,050,003 | -100.0% | -0.58% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -1,400,000 | -100.0% | -0.69% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -686,922 | -100.0% | -0.97% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -1,043,000 | -100.0% | -1.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-13
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.